Intra-Cellular Therapies, Inc.
NOVEL CO-CRYSTALS

Abstract:

The disclosure provides new, stable, pharmaceutically acceptable co-crystal forms of 1-(4-fluoro-phenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9, 10, 10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de[quinoxalin-8-yl- )-butan-1-one, together with methods of making and using them, and pharmaceutical compositions comprising them.